María Sofía Castelli (Sofia Castelli)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Infectious Diseases

Genome Wide Analysis

Top Venues

Nature communications

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

Ugur Uslu, Lijun Sun, María Sofía Castelli, Amanda V Finck, Charles-Antoine Assenmacher, Regina M Young, Zhijian J Chen, Carl H June
The STING agonist IMSA101 enhances chimeric antigen receptor T cell function by inducing IL-18 secretion. Nature communications 15 (1) (2024)
Ugur Uslu, Lijun Sun, María Sofía Castelli, Amanda V Finck, Charles-Antoine Assenmacher, Regina M Young, Zhijian J Chen, Carl H June
The STING agonist IMSA101 enhances chimeric antigen receptor T cell function by inducing IL-18 secretion. Nature communications 15 (1) (2024)
María Sofía Castelli, Regina M Young, Carl H June
Off-the-shelf CAR T cells to treat cancer. Cell research 32 (12) (2022)
Anusha Kalbasi, Mikko Siurala, Leon L Su, Mito Tariveranmoshabad, Lora K Picton, Pranali Ravikumar, Peng Li, Jian-Xin Lin, Helena Escuin-Ordinas, Tong Da, Sarah V Kremer, Amy L Sun, María Sofía Castelli, Sangya Agarwal, John Scholler, Decheng Song, Philipp C Rommel, Enrico Radaelli, Regina M Young, Warren J Leonard, Antoni Ribas, Carl H June, K Christopher Garcia
Potentiating adoptive cell therapy using synthetic IL-9 receptors. Nature 607 (7918) (2022)
María Sofía Castelli, Paul McGonigle, Pamela J Hornby
The pharmacology and therapeutic applications of monoclonal antibodies. Pharmacology research & perspectives 7 (6) (2020)